Docetaxel: all 1,319 studies that test it
Page 8 of 14. Open to participants first (111), then studies with results posted, then the rest; newest registration first within each.
- Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary CancerTerminatedNCT01773785Phase 2
- Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction CancerStatus unknownNCT01747707Phase 2
- Study of Chemotherapy Sequenced by or Combined With EGFR-TKIs for NSCLC Patients Failed to EGFR-TKIs TherapyStatus unknownNCT01746277Phase 2
- NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)CompletedNCT01726452Phase 3
- Docetaxel, Gemcitabine and Pazopanib as Treatment for Soft Tissue SarcomaCompletedNCT01719302Phase 1/2
- Salvage Docetaxel for Pretreated Urothelial CancerCompletedNCT01711112Phase 2
- A Phase II Trial of Epirubicin, Oxaliplatin and Capecitabine (EOX) Versus Docetaxel and Oxaliplatin (ElTax) in the Treatment of Advanced Gastro-oesophageal CancerCompletedNCT01710592Phase 2
- Reolysin in Previously Treated Advanced/Metastatic, Non Small Cell Lung Cancer Receiving Standard Salvage TherapyCompletedNCT01708993Phase 2
- A Phase 1, Dose Escalation Study to Assess the Safety and Tolerability of ASP9853 With Either Docetaxel or Paclitaxel in Patients With Advanced Non-hematologic MalignanciesTerminatedNCT01705483Phase 1
- Docetaxel and S-1 for Advanced Esophageal CancerStatus unknownNCT01693432Phase 2
- An Open-label, Multi-center Phase Ⅳ Trial to Evaluate the Efficacy and Safety of Sequential Neoadjuvant Chemotherapy With Docetaxel(Monotaxel®) After Doxorubicin Plus Cyclophosphamide Combination Chemotherapy in Locally Advanced Breast CancerCompletedNCT01660542Phase 4
- Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed by Radiotherapy in Stage IIIB Non-small Cell Lung CancerCompletedNCT01652820Phase 2
- "Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer"Status unknownNCT01641406Phase 2
- Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the StomachCompletedNCT01640782Phase 3
- Reolysin Combined With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Metastatic Castration Resistant Prostate CancerCompletedNCT01619813Phase 2
- Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer PatientsStatus unknownNCT01618474Phase 2
- A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid MalignanciesSuspendedNCT01604863Phase 1
- GP VS TP in the Treatment of Advanced Nasopharyngeal Carcinoma in Northwest ChinaCompletedNCT01596868Phase 2
- Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung CancerCompletedNCT01577654Phase 2
- Dose-dense Biweekly Docetaxel Combined With 5-fluorouracil as First-line Treatment in Advanced Gastric CancerCompletedNCT01567618Phase 2
- Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC)WithdrawnNCT01562301Phase 1
- Using Genetic Polymorphisms to Predict the Efficacy and Toxicity - A Gastric Adenocarcinoma StudyTerminatedNCT01558011Phase 2
- PI3K Inhibitor BKM120 and Docetaxel in Treating Patients With Advanced Solid Tumor That is Locally Advanced, Cannot Be Removed By Surgery, or MetastaticCompletedNCT01540253Phase 1
- Biochemical Recurrence Rate of Radical Prostatectomy Combined With Neoadjuvant and Adjuvant Chemotherapy in High Risk Prostate CancerStatus unknownNCT01530295Not applicable
- Docetaxel With or Without Metronomic Cyclophosphamide as First Line Chemotherapy in Metastatic Breast CancerStatus unknownNCT01526499Phase 2
- A Multicenter Phase II Study of Neoadjuvant Docetaxel, Cisplatin and Capecitabine and Protocolized Surgery in Resectable Gastric CancerCompletedNCT01517009Phase 2
- Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric AdenocarcinomasCompletedNCT01504256Phase 2
- A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line TreatmentStatus unknownNCT01497041Phase 2
- A Phase II Neo-adjuvant Study Assessing TCH (Docetaxel, Carboplatin and Trastuzumab) and TCHL (Docetaxel, Carboplatin, Trastuzumab and Lapatinib) in HER-2 Positive Breast Cancer Patients.CompletedNCT01485926Phase 2
- A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT01479504Phase 3
- Trial of Neoadjuvant Endostar, Docetaxel and Epirubicin for Patients With Breast CancerStatus unknownNCT01479036Phase 3
- Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or StomachCompletedNCT01472029Phase 2
- Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric CancerCompletedNCT01471470Phase 2
- Study of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell CancerCompletedNCT01469598Phase 2
- Induction Chemotherapy Followed by Cetuximab and Radiation Therapy for Head and Neck CancerCompletedNCT01467115Phase 2
- Efficacy Study of Chemotherapy Followed by Radiation Therapy to Treat Endometrial CancerStatus unknownNCT01461746Phase 2
- Pemetrexed Followed by Docetaxel or in Reverse SequenceCompletedNCT01442909Phase 4
- Individualized Chemotherapy Based on BRCA1 and RRM1 mRNA for Advanced Non-small Cell Lung Cancer (NSCLC)Status unknownNCT01424709Phase 2
- PET in Breast Cancer Receiving Neoadjuvant ChemotherapyCompletedNCT01396655Phase 2
- Pazopanib, Docetaxel, Prednisone ProstateCompletedNCT01385228Phase 1
- Trial of Docetaxel and Irinotecan (DI) for Recurrent or Refractory Bone and Soft Tissue Sarcomas.Status unknownNCT01380275Phase 2
- Study of Lenalidomide and Docetaxel in Subjects With Androgen Independent Prostate CancerCompletedNCT01378091Phase 1
- Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC)CompletedNCT01368848Phase 2
- A Phase II Study of Neoadjuvant Trastuzumab+Docetaxel+NPLD+/-Bevacizumab in Her2-pos. Early Breast CancerCompletedNCT01367028Phase 2
- A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung CancerCompletedNCT01362400Phase 2
- Safety and Clinical Pharmacology of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Paclitaxel, or Enzalutamide in Participants With Advanced Solid TumorsCompletedNCT01362374Phase 1
- Docetaxel, Oxaliplatin, Capecitabine, Bevacizumab and Trastuzumab in Patients With Locally Advanced or Metastatic Gastric CancerStatus unknownNCT01359397Phase 2
- Customizing First Line Chemotherapy in Advanced Non-Small Cell Lung CancerTerminatedNCT01356368Phase 2
- Docetaxel Combined With Cisplatin as First Line in Patients With Metastatic Non-small Cell Lung CancerSuspendedNCT01356303Phase 2
- TAC Versus TCX as Adjuvant Treatment for High-risk Her2-Negative Breast CancerCompletedNCT01354522Phase 3
- Neoadjuvant Chemotherapy With Docetaxel and Gemcitabine in Locally Advanced Breast CancerStatus unknownNCT01352494Phase 2
- A Clinical Trial of Docetaxel and Oxaliplatin in Patients With Recurrent or Metastatic Breast CancerStatus unknownNCT01351597Phase 2
- Pharmacokinetic Study of SYP-0704A and Taxotere to Treat Patient With Advanced Solid CancerCompletedNCT01336582Phase 1
- Sequential Chemotherapy With Xelox Follows by TX to Treat Gastric CancerStatus unknownNCT01331928Phase 2
- Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)CompletedNCT01326559Phase 2
- Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck CancerTerminatedNCT01313390Phase 1/2
- Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)CompletedNCT01312350Phase 2
- Weekly Docetaxel Plus Cisplatin as the First-line Therapy for Nasopharyngeal CancerStatus unknownNCT01312311Phase 2
- A Study of MM-111 in Combination With Multiple Treatments in Patients With HER2 Positive CancerCompletedNCT01304784Phase 1
- Early Cardiac Toxicity of Adjuvant CT in Elderly BC.TerminatedNCT01301040Phase 2
- Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable CancerCompletedNCT01295086Not applicable
- Neoadjuvant Combination Chemotherapy of DCS and DCF in Patients With Locally Advanced Gastric AdenocarcinomaCompletedNCT01286766Phase 2
- TaxoteRe Plus Cisplatin Versus AlImta Plus Cisplatin in 1st Line Non-squamous Cell Type Lung CancerTerminatedNCT01282151Phase 3
- Concurrent Chemoradiotherapy Using Intensity Modulated Radiotherapy (IMRT) & Docetaxel-cisplatin (or Carboplatin) Followed by Adjuvant Chemotherapy for Inoperable Stage III Non-small-cell Lung CancerCompletedNCT01266512Phase 2
- Feasibility of a Chemotherapy With Docetaxel-Prednisone for Castration-resistant Metastatic Prostate Cancer Elderly PatientsCompletedNCT01254513Phase 2
- Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT01245959Phase 3
- Safety Study for Intravenous (IV) AC480 (AC480IV) to Treat Advanced Solid TumorsWithdrawnNCT01245543Phase 1
- Sunitinib + Docetaxel as Second-line Treatment in Gastric CancerCompletedNCT01238055Phase 2
- Docetaxel and Oxaliplatin Combination With Locally Advanced or Metastatic Biliary Tract CancerStatus unknownNCT01234051Phase 2
- Cyclophosphamide and Docetaxel Every 3 Weeks as Neoadjuvant Therapy in Locally Advanced Breast CancerWithdrawnNCT01229605Phase 2
- Prostate Cancer, Androgen Deprivation Withdrawal and Intermittent ChemotherapyStatus unknownNCT01224405Phase 3
- 6xFU/Epirubicin/Cyclophosphamide (FEC) Compared to 3xFEC-3xDocetaxel in High-risk Node-negative Breast Cancer PatientsStatus unknownNCT01222052Phase 3
- 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric CancerCompletedNCT01216644Phase 2/3
- Bevacizumab, Docetaxel, and Carboplatin in Treating Women With Stage II or Stage III Breast CancerCompletedNCT01208480Phase 2
- CESAR Study in Prostate Cancer With Temsirolimus Added to Standard Docetaxel Therapy (CEPTAS)CompletedNCT01206036Phase 1/2
- A Study of the Safety and Efficacy of CNTO 888 in Combination With SoC (Standard of Care) Chemotherapy in Patients With Solid TumorsCompletedNCT01204996Phase 1
- Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer PatientsStatus unknownNCT01192230Phase 2
- Safety and Tolerability Study of GSK1120212, a MEK Inhibitor, in Combination With Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, Pemetrexed + Cisplatin, or Nab-PaclitaxelCompletedNCT01192165Phase 1
- 1-Methyl-D-Tryptophan and Docetaxel in Treating Patients With Metastatic Solid TumorsCompletedNCT01191216Phase 1
- Efficacy and Safety Study of LE-DT to Treat Metastatic Castrate Resistant Prostate CancerWithdrawnNCT01188408Phase 2
- Efficacy and Safety Study of LE-DT to Treat Locally Advanced or Metastatic Pancreatic CancerCompletedNCT01186731Phase 2
- InductionChemo-Radio-Antibody-TreatmentCompletedNCT01181401Phase 2
- Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid TumorsCompletedNCT01172028Phase 1
- Multicenter Study to Perioperative Chemotherapy for Resectable Adenocarcinoma in Gastric CancerStatus unknownNCT01160419Phase 2
- Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate CancerTerminatedNCT01155791Phase 1
- Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell CarcinomaActive, not recruitingNCT01154920Phase 2
- Liposome Encapsulated Docetaxel (LE-DT) in Patients With Solid TumorsCompletedNCT01151384Phase 1
- Study of Chemo-Immunotherapy in Head and Neck Cancer PatientsStatus unknownNCT01149902Phase 1
- A Study of Intravenous Aflibercept With Docetaxel in Chinese Patients With Solid TumorsCompletedNCT01148615Phase 1
- A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR MutationsStatus unknownNCT01131429Phase 2
- ABT-348 as Monotherapy or Combination With Carboplatin or Docetaxel to Treat Advanced Solid TumorsCompletedNCT01110486Phase 1
- Bevacizumab, Chemotherapy and Valproic Acid in Advanced SarcomasCompletedNCT01106872Phase 1
- Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel and Cisplatin in Patients With Solid TumorsCompletedNCT01095302Phase 1
- Imatinib Mesylate and Docetaxel in Non-Small Cell Lung Cancer (NSCLC)CompletedNCT01083589Phase 2
- Induction Docetaxel/Cisplatin/5-fluorouracil (TPF) as Selector for Chemo Radiation Therapy (RT) Versus Partial Laryngectomy in Advanced Laryngeal CancerStatus unknownNCT01073683Phase 2
- Second-Line Docetaxel + ASA404 for Advanced Urothelial CarcinomaWithdrawnNCT01071928Phase 2
- Docetaxel and Cisplatin Chemotherapy With or Without High Dose Proton Pump Inhibitor in Metastatic Breast CancerCompletedNCT01069081Phase 2
- Docetaxel and Sirolimus in Patients With Advanced MalignanciesCompletedNCT01054313Phase 1
- Lapatinib in Combination With Docetaxel in Patients With HER-2 Positive Advanced or Metastatic Breast CancerCompletedNCT01044485Phase 1/2
- Tax First-line Chemotherapy With Different Doses and Then Maintenance TherapyCompletedNCT01038661Phase 3